Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Active Ingredient: Proxymetacaine hydrochloride 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: SA Alcon Couvreur NV, Puurs, Belgium
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 25th day of September 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister
of Health on 11 September 2013).